Biosign and EasyMed Sign Distribution Agreements and Development and License Agreement

Biosign Technologies Inc. (TSX VENTURE:BIO) ("Biosign") and EasyMed Services
Inc. (CNSX:EZM)(OTCBB:EMYSF) ("EasyMed") are pleased to announce they have
executed agreements that allow the resale and distribution of each other's
respective products as well as a Development and License Agreement for the
creation of a joint product offering.


Under the terms of the Agreements:



--  Biosign will have access to resell and distribute EasyMed products
    within North America; 
--  EasyMed will have access to resell and distribute Biosign products
    within Europe; 
--  Biosign and EasyMed shall jointly develop new healthcare products and
    will share the revenue and intellectual property equally; 
--  EasyMed shall become a mobile technology provider for Biosign's future
    release of Healthanywhere(TM); and 
--  Biosign shall promote the "Powered by EasyMed" brand.



As previously reported, (see news December 5th, 2011), the companies intend to
interface UFIT(R) devices into Easy SmartCare and will make the offering
available within their respective territories. The combined solution provides
benefits for payers, providers, and patients through improved patient
preparation for medical visits, decreased absenteeism, better information for
both the patient and the caregiver, improved communication of medical results to
the patient, and enhanced outpatient management. 


"We have found a great partner to address the mobility of our product offering
in EasyMed" stated Dr. Scott Jenkins, CEO of Biosign, adding "Together our
companies are striving to provide the solutions that enable people to change the
way that they manage their health".


Andrew Ritchie, CEO of EasyMed commented, "The partnership between Biosign and
EasyMed will allow both companies to strengthen our product offering and take
advantage of our strong sales contacts in each of our markets. We also believe
that by developing a new product range that takes advantage of both companies
existing products and technology, that we will meet a new growing demand by
customers to be connected to their healthcare professionals by mobile or
internet technology. We are very pleased we were able to conclude the agreements
and can now start the process of building a new solution for healthcare".


About EasyMed Services Inc. 

EasyMed Services, Inc. (CNSX:EZM)(OTCBB:EMYSF) provides mobile healthcare
technology solutions that enhance the quality of care for patients and improve
healthcare system effectiveness. With EasyMed's mobile platform, caregivers and
patients can connect anywhere and anytime to share health information, schedule
and confirm visits, access medical records, provide care management for chronic
disease, and convey diagnostic results. For more information, visit
www.easymedmobile.com.


About Biosign Technologies Inc.

Biosign Technologies Inc. (TSX VENTURE:BIO) provides biomedical systems. Key
applications include intelligent systems for noninvasive monitoring of common
health risks associated with blood pressure, lifestyle, and medication. The core
technology combines measurement, analysis, and rapid knowledge formation to
support health monitoring across global markets. The UFIT(R) medical device
technology powers quality data collection and analytics for clinical
diagnostics, self-care, wellness, disease state evaluation & management, and
remote patient monitoring. For more information on Biosign, please visit
www.biosign.com. 


This news release contains forward-looking statements, which relate to future
events or future performance and reflect management's current expectations and
assumptions. These forward-looking statements reflect management's current
beliefs and are based on assumptions made by and information currently available
to the Company. Investors are cautioned that these forward looking statements
are neither promises nor guarantees, and are subject to risks and uncertainties
that may cause future results to differ materially from those expected. These
forward-looking statements are made as of the date hereof and, except as
required under applicable securities legislation, the Company does not assume
any obligation to update or revise them to reflect new events or circumstances.